These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29282189)

  • 1. Cutaneous Mucormycosis: A Fatal Complication of Immunosuppressant Therapy for Pemphigus Vulgaris.
    Sahni K; De D; Dogra S; Kanwar A; Saikia UN
    Skinmed; 2017; 15(6):467-469. PubMed ID: 29282189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kaur S; Kanwar AJ
    Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy.
    Heng YK; Lee JS; Neoh CY
    Int J Dermatol; 2012 Sep; 51(9):1044-6. PubMed ID: 22909356
    [No Abstract]   [Full Text] [Related]  

  • 10. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
    Pasricha JS; Das SS
    Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative treatment for pemphigus.
    Pasricha JS; Khaitan BK
    Arch Dermatol; 1996 Dec; 132(12):1518-9. PubMed ID: 8961890
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis.
    Sirois D; Leigh JE; Sollecito TP
    J Am Dent Assoc; 2000 Aug; 131(8):1156-60. PubMed ID: 10953530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
    Sethy PK; Khandpur S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports.
    Zhu CY; Yang YP; Sheng P; Li W; Huang WM; Fan YM
    Mycopathologia; 2015 Aug; 180(1-2):123-9. PubMed ID: 25821930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.
    Wever S; Zillikens D; Bröcker EB
    Br J Dermatol; 1996 Nov; 135(5):862-3. PubMed ID: 8977702
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal cutaneous mucormycosis after kidney transplant.
    Davuodi S; Manshadi SA; Salehi MR; Yazdi F; Khazravi M; Fazli JT
    Exp Clin Transplant; 2015 Feb; 13(1):82-5. PubMed ID: 25376012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus.
    Cohen MA; Cohen JJ; Kerdel FA
    Int J Dermatol; 2002 Jun; 41(6):340-4. PubMed ID: 12100688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
    Thakur BK; Bernardi DM; Murali MR; McClain SA; Clark RA
    J Am Acad Dermatol; 1998 Mar; 38(3):488-90. PubMed ID: 9520034
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term prognosis of pemphigus in central Kerala, India: a retrospective cohort study.
    Ajithkumar K
    Indian J Dermatol Venereol Leprol; 2014; 80(1):64-5. PubMed ID: 24448129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.